FIUZAT Mona, Durham, USA<br>Dr. Fiuzat is a Senior Research Associate in the Heart Failure Research Program at Duke University and Assistant Professor of Medicine in the Division of Clinical Pharmacology. She is also the Managing Deputy Editor of the new JACC-Heart Failure Journal. Dr. Fiuzat has worked at Solvay Pharmaceuticals and SmithKline Beecham Pharmaceuticals and was the Director of Clinical Operations and Development at ARCA biopharma, Inc. Her prior work experience included filing an NDA for the first proposed pharmacogenetically targeted heart failure drug and writing protocol and study development for Phase I, II and III studies, in both adults and pediatrics. Dr. Fiuzat’s clinical research experience has been in cardiovascular trials, with a focus on pharmacogenetics in heart failure. She is the Operational Leader of the PROTECT Publications Committee and a liaison for industry sponsors of clinical trials. Additionally, she has participated in the preparation for Cardio-renal Advisory Committee presentations to the FDA on behalf of drug sponsors.
Dr. Fiuzat completed undergraduate training at Clemson University and received her PharmD at Mercer University School of Pharmacy.